Expert second opinions for lvad (left ventricular assist device). Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
LVAD (Left Ventricular Assist Device) ) are mechanical pumps that help the failing heart circulate blood. If you are facing a decision about lvad (left ventricular assist device), an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Left ventricular assist devices (LVADs) are mechanical pumps that help the failing heart circulate blood. They serve as a bridge to heart transplant for eligible patients or as destination therapy (permanent support) for those not transplant candidates. Modern continuous-flow LVADs have dramatically improved outcomes.
LVAD implantation is a life-altering decision with significant implications for quality of life, complications, and long-term management. The distinction between bridge-to-transplant and destination therapy, assessment of right ventricular function (critical for LVAD success), and timing of implantation all require expert evaluation at an advanced heart failure center.
Surgery for lvad (left ventricular assist device) depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. LVAD implantation is a life-altering decision with significant implications for quality of life, complications, and long-term management. The distinction between bridge-to-transplant and destination therapy, assessment of right ventricular function (critical for LVAD success), and timing of implantation all require expert evaluation at an advanced heart failure center.
Operative mortality for lvad (left ventricular assist device)-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for lvad (left ventricular assist device) depends on anatomy, comorbidities, age, and personal goals. LVAD candidacy assessment. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.